Live Breaking News & Updates on Herdman Parschauer

Stay updated with breaking news from Herdman parschauer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pier 88 Investment Partners LLC Acquires 8,910 Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)

Pier 88 Investment Partners LLC grew its stake in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 76.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,590 shares of the biopharmaceutical company’s stock after acquiring an additional 8,910 shares during the […] ....

United States , Karah Herdman Parschauer , Robertw Baird , Matthewk Fust , Associates Corp , Investment Partners , International Assets Investment Management , Jpmorgan Chase Co , Covestor Ltd , Royal Bank , Allspring Global Investments Holdings , Canaccord Genuity Group , Ultragenyx Pharmaceutical Inc , Exchange Commission , Ultragenyx Pharmaceutical Company Profile , Cantor Fitzgerald , Ultragenyx Pharmaceutical , Free Report , Assets Investment Management , Global Investments Holdings , Get Free Report , Director Matthew , Herdman Parschauer , Genuity Group , Pharmaceutical Inc , North America ,

Ultragenyx Pharmaceutical (NASDAQ:RARE) Announces Quarterly Earnings Results, Misses Estimates By $0.31 EPS

Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) announced its quarterly earnings results on Thursday. The biopharmaceutical company reported ($2.03) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.72) by ($0.31), Briefing.com reports. Ultragenyx Pharmaceutical had a negative net margin of 138.58% and a negative return on equity of 421.88%. The business had […] ....

United States , Robertw Baird , Karah Herdman Parschauer , Matthewk Fust , Canaccord Genuity Group , Ultragenyx Pharmaceutical Inc , Securities Exchange Commission , Cantor Fitzgerald , Ultragenyx Pharmaceutical , Get Free Report , Genuity Group , Herdman Parschauer , Exchange Commission , Director Matthew , Pharmaceutical Inc , North America , Latin America , Ultragenyx Pharmaceutical Daily , Nasdaq Rare ,

Ultragenyx Pharmaceutical (NASDAQ:RARE) Coverage Initiated by Analysts at Royal Bank of Canada

Royal Bank of Canada began coverage on shares of Ultragenyx Pharmaceutical (NASDAQ:RARE – Free Report) in a report released on Monday, Marketbeat.com reports. The brokerage issued an outperform rating and a $77.00 price target on the biopharmaceutical company’s stock. Several other equities analysts have also recently commented on RARE. JPMorgan Chase & Co. upped their […] ....

United States , Robertw Baird , Karah Herdman Parschauer , Royal Bank , Allspring Global Investments Holdings , Securities Exchange Commission , Covestor Ltd , Associates Corp , Cantor Fitzgerald , Jpmorgan Chase Co , Canaccord Genuity Group , Ultragenyx Pharmaceutical Inc , Ultragenyx Pharmaceutical , Free Report , Genuity Group , Moderate Buy , Get Free Report , John Richard Pinion , Exchange Commission , Herdman Parschauer , State Retirement System , Global Investments Holdings , Pharmaceutical Inc , North America , Latin America , Ultragenyx Pharmaceutical Daily ,

China Universal Asset Management Co. Ltd. Raises Stake in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)

China Universal Asset Management Co. Ltd. raised its position in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 418.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,501 shares of the biopharmaceutical company’s stock after acquiring an additional 7,670 shares during the […] ....

New Zealand General , New Zealand , United States , Matthewk Fust , Karah Herdman Parschauer , Robertw Baird , China Universal Asset Management Co , Securities Exchange Commission , Blackrock Inc , Jpmorgan Chase Co , Canaccord Genuity Group , Wellington Management Group , Norges Bank , Ultragenyx Pharmaceutical Inc , Sands Capital Management , Wells Fargo Company , China Universal Asset Management , Ultragenyx Pharmaceutical , Free Report , Universal Asset Management , Capital Management , Street Corp , Management Group , Herdman Parschauer , Director Matthew , Get Free Report ,